Status:
COMPLETED
Validation of the Turkish Translation of the London Speech Evaluation Scale
Lead Sponsor:
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Conditions:
Speech Intelligibility
Speech Disorders
Eligibility:
All Genders
18-70 years
Brief Summary
Purpose of the study is the validation and cultual adaptation of the Turkish translation of the London Speech Evaluation Scale (LSE-T), so that it would be used as an assessment tool for Turkish head ...
Detailed Description
The speech function is a multidirectional process that depends on complex neuro-muscular network. The function can be evaluated using instrumental, such as voice analysis computer programmes, scales, ...
Eligibility Criteria
Inclusion
- Able to speak, read, understand and write in Turkish
- History of oral, orofarengeal cancer
- Volunteers who accept the informed consent
Exclusion
- Mental disorders
- Cognitive limitations
- Able not to speak, read, understand and write in Turkish
- Underwent any surgery last six month
- Permanent tracheostomy, total laryngectomy
- Pregnancy
- Out of age 18-70 years old
- Adults who do not accept the informed consent.
Key Trial Info
Start Date :
December 21 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 21 2021
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04690166
Start Date
December 21 2020
End Date
May 21 2021
Last Update
July 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prof Dr Cemil Tascioglu City Hospital
Istanbul, Turkey (Türkiye), 34384